Results 1 to 10 of about 52,437 (273)

Takayasu arteritis

open access: yesCurrent Opinion in Rheumatology, 2021
Purpose of review The purpose of this review is to summarize the recent advances in Takayasu arteritis (TAK), mainly focusing on pathogenesis, imaging modalities, and management. Recent findings Three novel clusters based on angiographic findings were identified in the Indian cohort
Sinem Nihal, Esatoglu, Gulen, Hatemi
semanticscholar   +4 more sources

Coexistence of Takayasu Arteritis and Intestinal Tuberculosis in a Young Bangladeshi Woman. [PDF]

open access: yesClin Case Rep
ABSTRACT Takayasu arteritis (TAK) is a rare, chronic, granulomatous large‐vessel vasculitis predominantly affecting young women. Although its etiology remains uncertain, tuberculosis (TB) has long been implicated as a potential trigger. We report a 28‐year‐old Bangladeshi woman with TAK coexisting with transverse colon TB, a rare but clinically ...
Debnath S   +5 more
europepmc   +2 more sources

Outcomes of an Intravenous to Subcutaneous Infliximab (CT-P13) Strategy in Takayasu Arteritis: A Proof-of-Concept Prospective Study. [PDF]

open access: yesACR Open Rheumatol
Objectives To evaluate persistence, outcomes, safety, and remission maintenance after switching from intravenous infliximab (IV‐IFX) to subcutaneous infliximab (SC‐IFX, CT‐P13) in patients with Takayasu arteritis (TA). Methods We conducted a prospective, single‐center, proof‐of‐concept observational study of consecutive adults with TA in sustained ...
Iorio L   +6 more
europepmc   +2 more sources

Takayasu arteritis

open access: yesDefinitions, 2020
A 31-year-old woman was admitted because of hypertension. She often had unexplained fever and had taken tranquilizers due to general malaise, with little effect, for a few months before admission.
Alexander McClanahan, Laura L. Hayes, MD
openaire   +2 more sources

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

open access: yesAnnals of the Rheumatic Diseases, 2022
To develop and validate new classification criteria for Takayasu arteritis (TAK).
P. Grayson   +12 more
semanticscholar   +2 more sources

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis

open access: yesArthritis & Rheumatology, 2021
To provide evidence‐based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis.
M. Maz   +31 more
semanticscholar   +1 more source

Outcomes of Percutaneous Intervention in Patients With Takayasu Arteritis.

open access: yesJournal of the American College of Cardiology, 2023
BACKGROUND The status of vascular lesion treatment using percutaneous intervention (PI) in Takayasu arteritis (TAK) remains unresolved. OBJECTIVES This study sought to develop PI strategies appropriate for TAK.
G. Joseph   +10 more
semanticscholar   +1 more source

Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis

open access: yesArthritis & Rheumatology, 2023
Tumor necrosis factor (TNF) alpha and interleukin‐17 (IL‐17) are thought to be involved in the pathogenesis of Takayasu arteritis (TAK), and TNF inhibitors (TNFi) are recommended for the treatment of TAK.
X. Tian   +12 more
semanticscholar   +1 more source

Tuberculosis and Takayasu arteritis: a case report 

open access: yesJournal of Medical Case Reports, 2023
Background Takayasu arteritis is a rare and chronic granulomatous vasculitis that affects the large vessels. Takayasu arteritis targets the aorta and its branches and is still of unknown etiology. It often affects female patients under 50 years of age. A
Maryem Ferjani   +6 more
doaj   +1 more source

Takayasu Arteritis: JACC Focus Seminar 3/4.

open access: yesJournal of the American College of Cardiology, 2022
Takayasu arteritis is a rare idiopathic large-vessel vasculitis that typically affects young women. An early "prepulseless" stage is often missed, associated with nonspecific constitutional symptoms (fever, malaise, and weight loss) and elevated ...
G. Joseph   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy